Related Experiment Video
Updated: Jun 27, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Syndecans and diabetic complications: A narrative review
Yasamin Rajabloo1, Maryam Saberi-Karimian2, Sara Saffar Soflaei3
1Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Syndecans (SDCs), a type of heparan sulfate proteoglycan, are decreased in diabetes mellitus (DM) complications. Understanding SDC molecular mechanisms is key to developing new treatments for diabetic conditions.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- Syndecans (SDCs) are heparan sulfate proteoglycans implicated in diabetic complications.
- Reduced SDC levels are observed in kidney, retina, and cardiac tissues in diabetes mellitus (DM) models.
- These reductions may contribute to albuminuria development in DM.
Purpose of the Study:
- To review the molecular mechanisms of SDCs in the development and progression of diabetic complications.
- To elucidate the complex role of SDCs and their associated molecular pathways in DM.
- To provide insights for developing novel therapeutic strategies for diabetic complications.
Main Methods:
- Literature review of studies on syndecans and diabetic complications.
- Analysis of molecular mechanisms underlying SDC function in diabetes.
- Synthesis of current evidence on SDC involvement in DM pathology.
Main Results:
- SDC levels are decreased in key organs affected by DM.
- Evidence suggests SDCs play a significant role in the pathogenesis of diabetic complications.
- Molecular mechanisms linking SDCs to DM progression are complex and require further investigation.
Conclusions:
- SDCs are critical in the pathophysiology of diabetic complications.
- Further research into SDC molecular mechanisms is essential for therapeutic development.
- Targeting SDCs may offer new avenues for preventing and treating diabetic complications.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

